Report cover image

Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Global Market Report 2025

Publisher The Business Research Company
Published Oct 23, 2025
Length 250 Pages
SKU # BRC20492512

Description

Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on next-generation sequencing (ngs)-based molecular diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for next-generation sequencing (ngs)-based molecular diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The next-generation sequencing (ngs)-based molecular diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Type: Instruments; Reagents And Consumables; Software And Services; Panels And Assays; Sample Preparation Kits

2) By Application: Microbiology; Infectious Diseases; Oncology; Genetic Tests; Other Applications

3) By End User: Research Centers And Academics; Hospitals And Clinical Laboratories; Other End Users

Subsegments:

1) By Instruments: Benchtop Sequencers; High-Throughput Sequencers; Portable Or Handheld Sequencers; Clinical Or Diagnostic Sequencers; Automated Library Preparation Systems; Data Analysis And Bioinformatics Hardware

2) By Reagents And Consumables: Sequencing Reagents And Kits; Library Preparation Reagents; Target Enrichment Reagents; Amplification Reagents; Sequencing Flow Cells And Chips; Deoxyribonucleic Acid (DNA) Or Ribonucleic Acid (RNA) Extraction Reagents; Quality Control Reagents

3) By Software And Services: Data Analysis Software; Bioinformatics Pipelines; Cloud-Based Genomic Platforms; Clinical Interpretation Tools; Data Storage And Management Services; Custom Bioinformatics Services; Genomic Database Services

4) By Panels And Assays: Oncology Panels; Infectious Disease Panels; Carrier Screening Panels; Reproductive Health Panels; Rare Disease Or Genetic Disorder Panels; Pharmacogenomics Panels; Whole-Exome Or Whole-Genome Assays

5) By Sample Preparation Kits: Deoxyribonucleic Acid (DNA) Extraction Kits; Ribonucleic Acid (RNA) Extraction Kits; Library Preparation Kits; Target Enrichment Kits; Amplification And Cleanup Kits; Single-Cell Preparation Kits; Low-Input Or Degraded Sample Kits

Companies Mentioned: Thermo Fisher Scientific; Siemens Healthineers AG; Agilent Technologies Inc.; Illumina Inc.; PerkinElmer Inc.; Bio-Rad Laboratories Inc.; Qiagen N.V.; Amoy Diagnostics Co. Ltd.; Tempus Labs Inc.; Myriad Genetics Inc.; Epigenomics AG; Precision for Medicine Inc.; Invitae Corporation; NeoGenomics Laboratories Inc.; Guardant Health Inc.; Caris Life Sciences Inc.; Foundation Medicine Inc.; Oxford Nanopore Technologies Ltd.; Freenome Inc.; Burning Rock Biotech; Element Biosciences Inc.; Asuragen Inc.; Bionano Genomics Inc.; Genomic Health Inc.; TATAA Biocenter AB

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery Format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Table of Contents

250 Pages
1. Executive Summary
2. Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Characteristics
3. Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Trends And Strategies
4. Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Growth Analysis And Strategic Analysis Framework
5.1. Global Next-Generation Sequencing (NGS)-Based Molecular Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Growth Rate Analysis
5.4. Global Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Total Addressable Market (TAM)
6. Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Segmentation
6.1. Global Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Instruments
Reagents And Consumables
Software And Services
Panels And Assays
Sample Preparation Kits
6.2. Global Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Microbiology
Infectious Diseases
Oncology
Genetic Tests
Other Applications
6.3. Global Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Research Centres And Academics
Hospitals And Clinical Laboratories
Other End Users
6.4. Global Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Benchtop Sequencers
High-Throughput Sequencers
Portable Or Handheld Sequencers
Clinical Or Diagnostic Sequencers
Automated Library Preparation Systems
Data Analysis And Bioinformatics Hardware
6.5. Global Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Sub-Segmentation Of Reagents And Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Sequencing Reagents And Kits
Library Preparation Reagents
Target Enrichment Reagents
Amplification Reagents
Sequencing Flow Cells And Chips
Deoxyribonucleic Acid (DNA) Or Ribonucleic Acid (RNA) Extraction Reagents
Quality Control Reagents
6.6. Global Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Sub-Segmentation Of Software And Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Data Analysis Software
Bioinformatics Pipelines
Cloud-Based Genomic Platforms
Clinical Interpretation Tools
Data Storage And Management Services
Custom Bioinformatics Services
Genomic Database Services
6.7. Global Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Sub-Segmentation Of Panels And Assays, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oncology Panels
Infectious Disease Panels
Carrier Screening Panels
Reproductive Health Panels
Rare Disease Or Genetic Disorder Panels
Pharmacogenomics Panels
Whole-Exome Or Whole-Genome Assays
6.8. Global Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Sub-Segmentation Of Sample Preparation Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Deoxyribonucleic Acid (DNA) Extraction Kits
Ribonucleic Acid (RNA) Extraction Kits
Library Preparation Kits
Target Enrichment Kits
Amplification And Cleanup Kits
Single-Cell Preparation Kits
Low-Input Or Degraded Sample Kits
7. Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Regional And Country Analysis
7.1. Global Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market
8.1. Asia-Pacific Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market
9.1. China Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Overview
9.2. China Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market
10.1. India Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market
11.1. Japan Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Overview
11.2. Japan Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market
12.1. Australia Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market
13.1. Indonesia Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market
14.1. South Korea Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Overview
14.2. South Korea Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market
15.1. Western Europe Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Overview
15.2. Western Europe Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market
16.1. UK Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market
17.1. Germany Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market
18.1. France Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market
19.1. Italy Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market
20.1. Spain Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market
21.1. Eastern Europe Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Overview
21.2. Eastern Europe Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market
22.1. Russia Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market
23.1. North America Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Overview
23.2. North America Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market
24.1. USA Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Overview
24.2. USA Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market
25.1. Canada Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Overview
25.2. Canada Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market
26.1. South America Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Overview
26.2. South America Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market
27.1. Brazil Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market
28.1. Middle East Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Overview
28.2. Middle East Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market
29.1. Africa Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Overview
29.2. Africa Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Competitive Landscape And Company Profiles
30.1. Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Competitive Landscape
30.2. Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Company Profiles
30.2.1. Thermo Fisher Scientific Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.5. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Other Major And Innovative Companies
31.1. Bio-Rad Laboratories Inc.
31.2. Qiagen N.V.
31.3. Amoy Diagnostics Co. Ltd.
31.4. Tempus Labs Inc.
31.5. Myriad Genetics Inc.
31.6. Epigenomics AG
31.7. Precision for Medicine Inc.
31.8. Invitae Corporation
31.9. NeoGenomics Laboratories Inc.
31.10. Guardant Health Inc.
31.11. Caris Life Sciences Inc.
31.12. Foundation Medicine Inc.
31.13. Oxford Nanopore Technologies Ltd.
31.14. Freenome Inc.
31.15. Burning Rock Biotech
32. Global Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market
34. Recent Developments In The Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market
35. Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market High Potential Countries, Segments and Strategies
35.1 Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market In 2029 - Countries Offering Most New Opportunities
35.2 Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market In 2029 - Segments Offering Most New Opportunities
35.3 Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us